For the quarter ending 2026-01-31, ZS had -$135,444K decrease in cash & cash equivalents over the period. $186,318K in free cash flow.
| Cash Flow | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 |
|---|---|---|---|---|
| Revenue | 815,751 | 788,112 | 2,673,115 | - |
| Adjusted cost of revenue | 161,463 | 158,329 | 532,067 | - |
| Adjusted sales and marketing expenses | 283,102 | 296,244 | 997,896 | - |
| Adjusted research and development expenses | 144,448 | 124,080 | 409,894 | - |
| Adjusted general and administrative expenses | 45,772 | 37,603 | 153,127 | - |
| Stock-based compensation expense and related payroll taxes | 220,413 | 193,761 | 685,534 | - |
| Amortization expense of acquired intangible assets | 11,114 | 8,633 | 16,820 | - |
| Restructuring and other charges | 0 | 4,741 | 4,921 | - |
| Acquisition-related expenses | 1,212 | 1,083 | 1,316 | - |
| Add other segment items, net | -17,461 | -24,747 | -86,982 | - |
| Net loss | -34,312 | -11,615 | -17,578 | -4,125 |
| Depreciation and amortization expense | 34,944 | 32,651 | 30,260 | 74,101 |
| Amortization expense of acquired intangible assets | 11,114 | 8,633 | 4,080 | 4,255 |
| Amortization of deferred contract acquisition costs | 49,551 | 48,082 | 44,811 | 42,308 |
| Amortization of debt issuance costs | 2,040 | 2,038 | 1,346 | 984 |
| Non-cash operating lease costs | 20,311 | 18,445 | 15,102 | 16,331 |
| Stock-based compensation expense | 216,553 | 188,593 | 172,654 | 159,401 |
| Accretion of investments purchased at a discount | 1,730 | 1,905 | 2,061 | 3,752 |
| Unrealized (gains) losses on hedging transactions | 4,094 | -3,033 | -1,231 | 3,898 |
| Deferred income taxes | -2,145 | 3,698 | -3,490 | 482 |
| Other | -1,204 | -1,234 | 72 | 244 |
| Accounts receivable | 21,330 | -482,861 | 376,516 | 101,537 |
| Deferred contract acquisition costs | 63,736 | 43,660 | 90,467 | 65,828 |
| Prepaid expenses, other current and noncurrent assets | 12,900 | 17,322 | 29,390 | 38 |
| Accounts payable | -19,175 | -2,942 | -11,415 | 28,849 |
| Accrued expenses, other current and noncurrent liabilities | -2,157 | 8,409 | 12,213 | 4,448 |
| Accrued compensation | 25,281 | -54,816 | 26,690 | 14,687 |
| Deferred revenue | 4,051 | -191,132 | 483,041 | 106,480 |
| Operating lease liabilities | 3,687 | 18,609 | 16,815 | 14,948 |
| Net cash provided by operating activities | 204,073 | 448,280 | 250,604 | 211,081 |
| Purchases of property, equipment and other assets | 17,755 | 17,311 | 60,046 | 72,163 |
| Capitalized internal-use software | 17,189 | 17,673 | 18,637 | 19,455 |
| Payments for business acquisitions, net of cash acquired | 0 | 672,780 | 0 | 0 |
| Purchase of strategic investments | 2,008 | 0 | 38 | 0 |
| Purchases of short-term investments | 505,081 | 896,388 | 393,993 | 157,570 |
| Proceeds from maturities of short-term investments | 149,210 | 93,593 | 225,132 | 270,890 |
| Proceeds from sale of short-term investments | 31,910 | 8,348 | 0 | 0 |
| Net cash used in investing activities | -360,913 | -1,502,211 | -247,582 | 21,702 |
| Proceeds from issuance of common stock upon exercise of stock options | 0 | 3,984 | 84 | 41 |
| Proceeds from issuance of common stock under the employee stock purchase plan | 21,506 | - | 41,219 | 0 |
| Payment of deferred consideration related to business acquisitions | 110 | - | 352 | 440 |
| Proceeds from issuance of the 2028 notes | - | - | 1,725,000 | - |
| Payments for issuance costs related to the 2028 notes | 0 | 684 | 24,150 | - |
| Purchases of capped calls related to the 2028 notes | 0 | 197 | 196,650 | - |
| Payments for the settlement of the 2025 notes | - | - | 1,150,040 | - |
| Other | - | - | 0 | - |
| Net cash provided by financing activities | 21,396 | 3,103 | 395,111 | -399 |
| Net increase (decrease) in cash and cash equivalents | -135,444 | -1,050,828 | 398,133 | 232,384 |
| Cash and cash equivalents at beginning of period | 1,338,195 | 2,389,023 | 1,990,890 | 1,758,506 |
| Cash and cash equivalents at end of period | 1,202,751 | 1,338,195 | 2,389,023 | 1,990,890 |
Zscaler, Inc. (ZS)
Zscaler, Inc. (ZS)